Rapid start-up for Early Phase biotechs
The biotech drug development journey with Avance Clinical starts with robust early phase clinical foundations.
Avance Clinical’s ClinicReady is the surrogate or outsourced drug development team for preclinical biotechs. The ClinicReady scientific and regulatory affairs process supports demonstration of safety and preliminary clinical Proof of Concept (POC) and lays the vital clinical foundations that ensures seamless transition into phase one and beyond.
Our experienced team of professionals navigate biotechs through study design, protocol development, and regulatory requirements. From Phase I studies involving healthy volunteers or hybrid studies, to Phase II trials assessing initial efficacy in patient populations, the team plans around the specific needs and objectives of each trial and implements the most robust clinical processes.
Our partnership relationships with leading labs and Phase 1 units means Early Phase studies are seamlessly and rapidly implemented.
DISCUss your trial with our scientific experts
Contact us for a confidential discussion
OUR Early Phase CLINICAL TRIAL
EXPERTISE
The ClinicReady team of experts
Start the early phase with your surrogate drug development team
Proven site network
Avance Clinical has a powerful network of proven PIs and clinical sites
World-class data
Avance Clinical data is accepted by all the major regulatory authorities including the FDA and EMA.
Phase 1 Units network
Avance Clinical offers a proven network of world-class Phase 1 Units
No IND required
In Australia our biotech clients start their Phase I without having to wait for an IND, saving up to a year in regulatory processing times and considerable costs.
5-6 week start-up
With the Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks it enables you to get access to clinical data quickly and gain that critical Go/No Go information on your product faster than anywhere else in the world.
Up to 43.5 % rebate
Biotechs can save 43.5% with the Australian Government’s attractive rebate to support clinical trials in Australia
WHY BIOTECHS CHOOSE
AVANCE CLINICAL
More than three decades of deep clinical research management experience, Avance Clinical is the largest
specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand, Asia and North America for international biotechs.
UP TO 43.5%
REBATE
5-6 Wks
START-UP TIME
100%
CAPABILITIES
FDA
COMPLIANT RESEARCH